» Articles » PMID: 22509284

Phosphorylation of Ubc9 by Cdk1 Enhances SUMOylation Activity

Overview
Journal PLoS One
Date 2012 Apr 18
PMID 22509284
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Increasing evidence has pointed to an important role of SUMOylation in cell cycle regulation, especially for M phase. In the current studies, we have obtained evidence through in vitro studies that the master M phase regulator CDK1/cyclin B kinase phosphorylates the SUMOylation machinery component Ubc9, leading to its enhanced SUMOylation activity. First, we show that CDK1/cyclin B, but not many other cell cycle kinases such as CDK2/cyclin E, ERK1, ERK2, PKA and JNK2/SAPK1, specifically enhances SUMOylation activity. Second, CDK1/cyclin B phosphorylates the SUMOylation machinery component Ubc9, but not SAE1/SAE2 or SUMO1. Third, CDK1/cyclin B-phosphorylated Ubc9 exhibits increased SUMOylation activity and elevated accumulation of the Ubc9-SUMO1 thioester conjugate. Fourth, CDK1/cyclin B enhances SUMOylation activity through phosphorylation of Ubc9 at serine 71. These studies demonstrate for the first time that the cell cycle-specific kinase CDK1/cyclin B phosphorylates a SUMOylation machinery component to increase its overall SUMOylation activity, suggesting that SUMOylation is part of the cell cycle program orchestrated by CDK1 through Ubc9.

Citing Articles

SUMOylation of protein phosphatase 5 regulates phosphatase activity and substrate release.

Sager R, Backe S, Dunn D, Heritz J, Ahanin E, Dushukyan N EMBO Rep. 2024; 25(11):4636-4654.

PMID: 39304777 PMC: 11549447. DOI: 10.1038/s44319-024-00250-2.


Stabilization of Pin1 by USP34 promotes Ubc9 isomerization and protein sumoylation in glioma stem cells.

Zhu Q, Liang P, Meng H, Li F, Miao W, Chu C Nat Commun. 2024; 15(1):40.

PMID: 38167292 PMC: 10762127. DOI: 10.1038/s41467-023-44349-x.


Targeting CDK1 in cancer: mechanisms and implications.

Wang Q, Bode A, Zhang T NPJ Precis Oncol. 2023; 7(1):58.

PMID: 37311884 PMC: 10264400. DOI: 10.1038/s41698-023-00407-7.


Phosphorylation of VP1 Mediated by CDK1-Cyclin B1 Facilitates Infectious Bursal Disease Virus Replication.

Hu X, Chen Z, Wu X, Ding Z, Huang Y, Fu Q J Virol. 2023; 97(1):e0194122.

PMID: 36602364 PMC: 9888224. DOI: 10.1128/jvi.01941-22.


Role of SUMOylation in Neurodegenerative Diseases.

Mandel N, Agarwal N Cells. 2022; 11(21).

PMID: 36359791 PMC: 9654019. DOI: 10.3390/cells11213395.


References
1.
Munarriz E, Barcaroli D, Stephanou A, Townsend P, Maisse C, Terrinoni A . PIAS-1 is a checkpoint regulator which affects exit from G1 and G2 by sumoylation of p73. Mol Cell Biol. 2004; 24(24):10593-610. PMC: 533962. DOI: 10.1128/MCB.24.24.10593-10610.2004. View

2.
Losada A, Hirano T . Dynamic molecular linkers of the genome: the first decade of SMC proteins. Genes Dev. 2005; 19(11):1269-87. DOI: 10.1101/gad.1320505. View

3.
Chen T, Hsu C, Chang K, Ting C, Whang-Peng J, Hui C . Development of DNA delivery system using Pseudomonas exotoxin A and a DNA binding region of human DNA topoisomerase I. Appl Microbiol Biotechnol. 2000; 53(5):558-67. DOI: 10.1007/s002530051657. View

4.
Tanaka K, Nishide J, Okazaki K, Kato H, Niwa O, Nakagawa T . Characterization of a fission yeast SUMO-1 homologue, pmt3p, required for multiple nuclear events, including the control of telomere length and chromosome segregation. Mol Cell Biol. 1999; 19(12):8660-72. PMC: 85006. DOI: 10.1128/MCB.19.12.8660. View

5.
Azuma Y, Arnaoutov A, Anan T, Dasso M . PIASy mediates SUMO-2 conjugation of Topoisomerase-II on mitotic chromosomes. EMBO J. 2005; 24(12):2172-82. PMC: 1150894. DOI: 10.1038/sj.emboj.7600700. View